Isak from Norway

Registered at the short selling broker eToro, 2 minutes ago.

» Try eToro you too
75% of retail investor accounts lose money when trading CFDs with etoro.
Don't show again

Takeda Pharmaceutical Co., Ltd (TAK) shares information

Takeda Pharmaceutical Co – ADR


24h Change

-1.59 %

TAK

Live rate: Market closed

Stock data per Thursday 21 Jan, 2021

TAK
NEW YORK STOCK EXCHANGE, INC.
17.58
17.41
17.30
-0.28 (-1.59%)
US Market is closed

Live Stock price in graph for Takeda Pharmaceutical Co – ADR (TAK)

  • Latest Volume

    4,589,089 (2.8 %)

  • Volume prev. day

    4,463,977

  • Avg. daily volume

    3,198,695

  • Market cap

    54,542,537,217

  • P/E ratio

    n/a

  • Today high

    17.517 USD

  • Today low

    17.25 USD

  • 52 week high

    19.31 USD

  • 52 week low

    12.38 USD

  • YTD Change

    n/a

Quick links

 

Latest news about Takeda Pharmaceutical Co – ADR

Below you can find the most recent news posts about Takeda Pharmaceutical Co – ADR, primarily from US and UK based news sources.

Schlichter Strikes Again, This Time Against Takeda Pharma's 401(k) | PLANADVISER

Thursday, 21 January 2021, 19:21:39
The lawsuit alleges that plan fiduciaries selected unproven TDFs for the plan, failed to monitor them and failed to replace them when they underperformed.
— PLANADVISER


Takeda Provides Pipeline Update and Shares Goal to Increase Revenue 50% by FY2030 at the 39th Annual J.P. Morgan Healthcare Conference

Monday, 11 January 2021, 23:20:00
OSAKA, Japan & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) provided an update on the progress of its continued transformation and growth today at the virtual 39th Annual J.P. Morgan Healthcare Conference. President and Chief Executive Officer, Christophe Weber, shared details on Takeda’s portfolio and pipeline strategy and financial outlook, including key programs expected to contribute to the company’s revenue growth over the next dec
— Business Wire


Takeda to Present at The 39th Annual J.P. Morgan Healthcare Conference

Monday, 11 January 2021, 13:00:00
OSAKA, Japan & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) (“Takeda”) will present virtually at the 39th Annual J.P. Morgan Healthcare Conference at 5:20 p.m. ET on Monday, January 11, 2021 / 7:20 a.m. JT on Tuesday, January 12, 2021. Investors and the general public are invited to listen to the live webcast with Christophe Weber, president and chief executive officer, here. A replay of the webcast will also be archived at the same location. A
— Business Wire


H4 Antagonist Market Anticipated to Grow at a CAGR of 12.0% during the Forecast Period | Sanofi, Merck & Co. Inc., Takeda Pharmaceutical Company Ltd., Pfizer, Inc., Novartis International AG

Sunday, 10 January 2021, 03:48:07
Jan 09, 2021 (Market Insight Reports) — The size of the Global H4 Antagonist Market is projected to grow at a CAGR of 12.0% during the forecast period. The…
— MarketWatch


Global Autism Drug Market Promising Growth Opportunities over 2019 To 2026||Top Leaders-ALLERGAN, AbbVie Inc, Johnson & Johnson Services, Takeda Pharmaceutical Company Limited

Monday, 4 January 2021, 08:43:52
A complete overview of the Autism Drug Market industry has been presented via the credible Autism Drug Market report which considers various aspects of product definition, market segmentation, and therefore the existing retailer landscape. This marketing research report is produced
— OpenPR


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €200
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have TAK available or trade one of the many other CFD stocks they have.
Risk warning: 75% of retail investor accounts lose money when trading CFDs with Capital.